Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
California Healthcare Institute
CHI Submits Statement on Follow-On Biologics Legislation
March 28th, 2009
The following statement was issued by California Healthcare Institute (CHI) President and Chief Executive Officer David Gollaher, Ph.D., regarding legislation introduced today by Rep. Henry Waxman (D-CA), Rep. Frank Pallone (D-NJ), Rep. Nathan Deal (R-GA) and Rep. Jo Ann Emerson (R-MO) to establish a pathway for the approval of follow-on biologic drugs. “California Healthcare Institute supports the creation of a science-based pathway for the U.S. Food and Drug Administration (FDA) to review and approve follow-on biologic drugs. But we are concerned that the legislation introduced today by Chairman Waxman, Representatives Pallone, Deal and Emerson may actually hinder the...
Source: Law & Health Weekly (2009-03-28)
|
